Bernama’s Mogesh Enters Malaysia Book Of Records For Immunobiology PhD

Kuala lumpur: Bernama TV English newsreader Dr. Mogesh Sababathy, 27, made history today by graduating with a Doctor of Philosophy (PhD) in Immunobiology from Universiti Putra Malaysia (UPM) and being recognized by the Malaysia Book of Records (MBOR).

According to BERNAMA News Agency, Mogesh was named the 'First News Presenter with a Doctorate in Immunobiology' by MBOR. He expressed his gratitude for the recognition and dedicated his achievements to his family, friends, and supervisory committee who supported him throughout his PhD journey. He emphasized his passion for research in stem cells and immunology, with aspirations to be recognized as an expert internationally.

The MBOR recognition plaque was presented to Mogesh by official representative Siti Hajar Johor, in the presence of UPM's Faculty of Veterinary Medicine dean Prof. Dr. Goh Yong Meng and Bernama Commercial Department head Mastura Hassan. Mogesh shared that his interest in stem cell therapy was sparked when his father faced a serious accident and stem cell treatment was suggested but deemed too costly and advanced for recovery at the time.

Mogesh's motivation to pursue studies in immunology and stem cells stems from his desire to make medical treatments more accessible and affordable. He aims to contribute to the field of lung inflammation research using stem cells, inspired by his father's doctors' suggestions. Mogesh hopes to make therapeutic strategies more available to those in need.

Joining Bernama in 2022, Mogesh was initially spotted during a guest appearance discussing climate change. He credits Cik Suriati Sanusi, head of the English Desk at Bernama TV, for giving him the opportunity to become a newsreader. Mogesh currently anchors weekend news, including the world news segment.

He believes that presenting news has improved his ability to communicate scientific findings effectively, a skill crucial for enhancing public understanding of research. Mogesh plans to continue contributing to immunology and stem cell research while remaining active in broadcasting.